Evidence map›Paper›PMID 25680959›Full record

ArticleMolecular & cellular proteomics : MCP2015

Serial analysis of 38 proteins during the progression of human breast tumor in mice using an antibody colocalization microarray.

Huiyan Li, Sébastien Bergeron, Matthew G Annis, Peter M Siegel, David Juncker

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Huiyan LiFrom the ‡Biomedical Engineering Department, §McGill University and Genome Quebec Innovation Centre.
Sébastien BergeronFrom the ‡Biomedical Engineering Department, §McGill University and Genome Quebec Innovation Centre.
Matthew G Annis‖Rosalind and Morris Goodman Cancer Research Centre, and.
Peter M Siegel‖Rosalind and Morris Goodman Cancer Research Centre, and.
David JunckerFrom the ‡Biomedical Engineering Department, §McGill University and Genome Quebec Innovation Centre, **Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec H3A 0G1, Canada david.juncker@mcgill.ca.
McGill University and Génome Québec Innovation Centre · CAGoodman (Japan) · JPMcGill University · CAOccupational Cancer Research Centre · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Proteins in serum or plasma hold great potential for use in disease diagnosis and monitoring. However, the correlation between tumor burden and protein biomarker concentration has not been established. Here, using an antibody colocalization microarray, the protein concentration in serum was measured and compared with the size of mammary xenograft tumors in 11 individual mice from the time of injection; seven blood samples were collected from each tumor-bearing mouse as well as control mice on a weekly basis. The profiles of 38 proteins detected in sera from these animals were analyzed by clustering, and we identified 10 proteins with the greatest relative increase in serum concentration that correlated with growth of the primary mammary tumor. To evaluate the diagnosis of cancer based on these proteins using either an absolute threshold (i.e. a concentration cutoff) or self-referenced differential threshold based on the increase in concentration before cell injection, receiver operating characteristic curves were produced for 10 proteins with increased concentration, and the area under curve was calculated for each time point based on a single protein or on a panel of proteins, in each case showing a rapid increase of the area under curve. Next, the sensitivity and specificity of individual and optimal protein panels were calculated, showing high accuracy as early as week 2. These results provide a foundation for studies of tumor growth through measuring serial changes of protein concentration in animal models.

Indexed as

Disease ProgressionAnimalsAntibodies, NeoplasmBiomarkers, TumorBlood ProteinsBreast NeoplasmsCell Line, TumorCell ProliferationCluster AnalysisFemaleHumansImmunoassayMammary Neoplasms, AnimalMiceNeoplasm ProteinsProtein Array AnalysisAntibodies, NeoplasmBiomarkers, TumorBlood ProteinsNeoplasm Proteins

Identifiers

PMID25680959
PMCPMC4390249
OpenAlexW2097275194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.